↓ Skip to main content

Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection

Overview of attention for article published in Frontiers in immunology, February 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
5 X users
patent
1 patent
f1000
1 research highlight platform

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
66 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection
Published in
Frontiers in immunology, February 2017
DOI 10.3389/fimmu.2017.00041
Pubmed ID
Authors

Silke Heidenreich, Nicolaus Kröger

Abstract

Besides donor T cells, natural killer (NK) cells are considered to have a major role in preventing relapse after allogeneic hematopoietic stem cell transplantation (HSCT). After T-cell-depleted haploidentical HSCT, a strong NK alloreactivity has been described. These effects have been attributed to killer-cell immunoglobulin-like receptors (KIR). Abundant reports suggest a major role of KIR not only on outcome after haploidentical HSCT but also in the unrelated donor setting. In this review, we give a brief overview of the mechanism of NK cell activation, nomenclature of KIR haplotypes, human leukocyte antigen (HLA) groups, and distinct models for prediction of NK cell alloreactivity. It can be concluded that KIR-ligand mismatch seems to provoke adverse effects in unrelated donor HSCT with reduced overall survival and increased risk for high-grade acute graft-versus-host disease. The presence of activating KIR, as seen in KIR haplotype B, as well as the patient's HLA C1/x haplotype might reduce relapse in myeloid malignancies.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Germany 1 2%
Unknown 64 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 15%
Student > Ph. D. Student 9 14%
Other 8 12%
Researcher 8 12%
Student > Doctoral Student 5 8%
Other 11 17%
Unknown 15 23%
Readers by discipline Count As %
Medicine and Dentistry 21 32%
Immunology and Microbiology 9 14%
Biochemistry, Genetics and Molecular Biology 5 8%
Agricultural and Biological Sciences 5 8%
Engineering 2 3%
Other 6 9%
Unknown 18 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2021.
All research outputs
#5,213,149
of 25,382,440 outputs
Outputs from Frontiers in immunology
#5,672
of 31,531 outputs
Outputs of similar age
#99,408
of 424,548 outputs
Outputs of similar age from Frontiers in immunology
#76
of 384 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 31,531 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,548 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 384 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.